In this episode, Micah Murray explains how SYNERGIES and these encounters with the PLEX Research Partners brings concrete and practical benefits to his research approach…
Meeting 03 Episode 01 – So who are we going to play upfront?
Now the preliminary discussions are over, Sean and the GLAD PLEX-RPs begin to address the prerequisites for the research project – first up is filling the PhD candidate for the PI position…
Meeting 04 Episode 01 – Lifting the Curtain…
To help the rTMS team get a clearer picture of the process at the heart of the research project, a quick tour of the equipment involved is in order – and a chance to lift the laboratory curtain…
Meeting 02 Episode 03 – “Putting order into disorders…”
Does the test help to establish the optimal dosage of an existing drug regime or is it designed to indicate which molecule to use in the first place? Sean explains the way the body processes drugs to clarify the situation…
Meeting 03 Episode 02 – “A PhD deconstruction…”
One of the key considerations of rTMS therapy is the individual treatment duration and the overall period of treatment required to effectively alleviate symptoms. In this video it’s time for some timely advice…
Meeting 04 Episode 01 – Is research funding founded on fads?
Funding for research is a tough nut to crack, especially when you are up against projects which appeal to established parameters or have “preordained” high-profile objectives. Isabelle laments the paucity of financing available to ‘lean, mean and provocative” projects that question fashionable assumptions…
Meeting 02 Episode 06 – The importance of environmental considerations when analysing the brain…
What if we were more than just our brains? Alexandre asks about the significance of a person’s environment and how that can impact any form of latent psychosis. Micah agrees that beyond any existing genetic precursors, how we experience the world can trigger or accentuate psychotic predispositions…
Meeting 02 Episode 02 – Does dose matter more…?
Does the test help to establish the optimal dosage of an existing drug regime or is it designed to indicate which molecule to use in the first place? Sean explains the way the body processes drugs to clarify the situation…
Meeting 03 Episode 01 – Walking the ethical line…
One of the key considerations of rTMS therapy is the individual treatment duration and the overall period of treatment required to effectively alleviate symptoms. In this video it’s time for some timely advice…
Meeting 03 Episode 06 – Ideas for future collaboration…
Now that the Zurich SYNERGIES programme has attained cruising speed, Isabelle and the PLEX-RPs start to explore the possibility of other types of collaboration with a view to future publication…